• Access to more than 350 million population in the Middle East and North Africa

​

​

• Flexibility: We support clinical trials by our private clinics, community hospitals or by our network of academic and governmental hospitals

​

• Work smoothly with sponsors directly or with CRO’s to compliment any needed services